{"transactions":[{"id":713966,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-07-08T01:44:39.000Z","date":"2026-07-06","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":23573,"derivative":{"exercise_price":1.2,"expiration_date":"2036-07-06","underlying":"Common stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-022963","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926022963/rdgdoc.xml","form_type":"4"}},{"id":737662,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:10:21.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":7.218,"value":158796.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":58322,"source":{"system":"sec-edgar","filing":"0001437749-26-020704","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020704/rdgdoc.xml","form_type":"4"}},{"id":737661,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:10:21.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":80322,"source":{"system":"sec-edgar","filing":"0001437749-26-020704","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020704/rdgdoc.xml","form_type":"4"}},{"id":881729,"issuer":{"id":8004,"kind":"organization","name":"Sintx Technologies, Inc."},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T14:00:02.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.91,"value":2910.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001493152-26-007964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269026/000149315226007964/ownership.xml","form_type":"4"}},{"id":975129,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-12-11T02:52:56.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":15573,"derivative":{"exercise_price":1.37,"expiration_date":"2035-12-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001437749-25-037471","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774925037471/rdgdoc.xml","form_type":"4"}},{"id":1054419,"issuer":{"id":8004,"kind":"organization","name":"Sintx Technologies, Inc."},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-27T12:00:03.000Z","date":"2025-08-26","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.5854,"value":10756.2,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001493152-25-012367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269026/000149315225012367/ownership.xml","form_type":"4"}},{"id":1107817,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:46:13.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.4,"value":74800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":53322,"source":{"system":"sec-edgar","filing":"0001437749-25-020715","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020715/rdgdoc.xml","form_type":"4"}},{"id":1111409,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:16:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":75322,"source":{"system":"sec-edgar","filing":"0001437749-25-020361","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020361/rdgdoc.xml","form_type":"4"}},{"id":1386203,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-10-17T01:55:51.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":3573,"derivative":{"exercise_price":2.65,"expiration_date":"2034-10-11","underlying":"Common stock","underlying_shares":829},"source":{"system":"sec-edgar","filing":"0001437749-24-031409","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774924031409/rdgdoc.xml","form_type":"4"}},{"id":1471915,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:19:26.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":48322,"source":{"system":"sec-edgar","filing":"0001437749-24-021016","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021016/rdgdoc.xml","form_type":"4"}},{"id":1477153,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:21:26.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.3394,"value":73466.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":21322,"source":{"system":"sec-edgar","filing":"0001437749-24-020568","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020568/rdgdoc.xml","form_type":"4"}},{"id":1757666,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-10-19T21:03:14.000Z","date":"2023-10-18","kind":"grant","planned":false,"acquired":true,"shares":12434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":41233,"derivative":{"exercise_price":0.4029,"expiration_date":"2033-10-18","underlying":"Common stock","underlying_shares":12434},"source":{"system":"sec-edgar","filing":"0001437749-23-028621","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774923028621/rdgdoc.xml","form_type":"4"}},{"id":1854153,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:10:23.000Z","date":"2023-06-13","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":43322,"source":{"system":"sec-edgar","filing":"0001437749-23-017610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017610/rdgdoc.xml","form_type":"4"}},{"id":1854152,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:10:23.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.4532,"value":75970.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-16-2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":16322,"source":{"system":"sec-edgar","filing":"0001437749-23-017610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017610/rdgdoc.xml","form_type":"4"}},{"id":1965399,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T00:50:20.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer."}],"balance_after":51800,"derivative":{"exercise_price":3.8,"expiration_date":"2033-03-06","underlying":"Class A Common Stock","underlying_shares":51800},"source":{"system":"sec-edgar","filing":"0001534969-23-000017","document":"wf-form4_167823660648362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000153496923000017/wf-form4_167823660648362.xml","form_type":"4"}},{"id":1965398,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-08T00:50:20.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 6, 2023, subject to the reporting person continuing to provide services to the issuer."}],"balance_after":35630,"source":{"system":"sec-edgar","filing":"0001534969-23-000017","document":"wf-form4_167823660648362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000153496923000017/wf-form4_167823660648362.xml","form_type":"4"}},{"id":2149033,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-09-30T21:03:20.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":12434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant."}],"balance_after":28789,"derivative":{"exercise_price":1.44,"expiration_date":"2032-06-10","underlying":"Common stock","underlying_shares":12434},"source":{"system":"sec-edgar","filing":"0001437749-22-023326","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774922023326/rdgdoc.xml","form_type":"4"}},{"id":2225265,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-21T23:05:16.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":22858,"price":2.6411,"value":60370.2638,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price."}],"balance_after":38322,"source":{"system":"sec-edgar","filing":"0001437749-22-015524","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015524/rdgdoc.xml","form_type":"4"}},{"id":2227456,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-17T20:22:39.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":61180,"source":{"system":"sec-edgar","filing":"0001437749-22-015294","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015294/rdgdoc.xml","form_type":"4"}},{"id":2250054,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T20:07:41.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of May 31, 2023 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":4400,"derivative":{"exercise_price":6.9,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001209191-22-033132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122033132/doc4.xml","form_type":"4"}},{"id":2317575,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-25T20:34:01.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":168275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest over four years beginning on the grant date of March 23, 2022 as follows: 15% of the original grant amount vests in equal monthly installments over the first year following the grant date, 20% of the original grant amount vests in equal monthly installments over the second year following the grant date, 25% of the original grant amount vests in equal monthly installments over the third year following the grant date, and 40% of the original grant amount vests in equal monthly installments over the fourth year following the grant date, subject to the reporting person continuing to provide services to the issuer."}],"balance_after":168275,"derivative":{"exercise_price":3.75,"expiration_date":"2032-03-23","underlying":"Class A Common Stock","underlying_shares":168275},"source":{"system":"sec-edgar","filing":"0001534969-22-000019","document":"wf-form4_164824040790992.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000153496922000019/wf-form4_164824040790992.xml","form_type":"4"}},{"id":2628009,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B-1 Preferred Stock","published_at":"2021-07-21T22:02:26.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001104659-21-094520","document":"tm2122781-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000110465921094520/tm2122781-4_4seq1.xml","form_type":"4"}},{"id":2628008,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A-2 Preferred Stock","published_at":"2021-07-21T22:02:26.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2455},"source":{"system":"sec-edgar","filing":"0001104659-21-094520","document":"tm2122781-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000110465921094520/tm2122781-4_4seq1.xml","form_type":"4"}},{"id":2628007,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-21T22:02:26.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date."}],"balance_after":2830,"source":{"system":"sec-edgar","filing":"0001104659-21-094520","document":"tm2122781-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000110465921094520/tm2122781-4_4seq1.xml","form_type":"4"}},{"id":2628006,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-21T22:02:26.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":2455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date."}],"balance_after":2455,"source":{"system":"sec-edgar","filing":"0001104659-21-094520","document":"tm2122781-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191062/000110465921094520/tm2122781-4_4seq1.xml","form_type":"4"}},{"id":2663415,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T23:21:47.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":27858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":34180,"source":{"system":"sec-edgar","filing":"0001209191-21-041706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121041706/doc4.xml","form_type":"4"}},{"id":2669173,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T00:47:50.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":12434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant."}],"balance_after":16355,"derivative":{"exercise_price":4.43,"expiration_date":"2031-06-15","underlying":"Common stock","underlying_shares":12434},"source":{"system":"sec-edgar","filing":"0001437749-21-014878","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921014878/rdgdoc.xml","form_type":"4"}},{"id":2671715,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T21:36:56.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":25248,"price":11.3617,"value":286860.2016,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.24 to $11.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6322,"source":{"system":"sec-edgar","filing":"0001209191-21-039954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121039954/doc4.xml","form_type":"4"}},{"id":2715140,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-13T20:27:08.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of May 11, 2022 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":3750,"derivative":{"exercise_price":9.9,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-21-032339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919121032339/doc4.xml","form_type":"4"}},{"id":2754800,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-08T00:22:31.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":3456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted March 31, 2021, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":54267,"source":{"system":"sec-edgar","filing":"0001437749-21-008505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921008505/rdgdoc.xml","form_type":"4"}},{"id":2922864,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-06T02:54:16.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":50811,"source":{"system":"sec-edgar","filing":"0001437749-21-000194","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921000194/rdgdoc.xml","form_type":"4"}},{"id":2922863,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-01-06T02:54:16.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":47061,"source":{"system":"sec-edgar","filing":"0001437749-21-000194","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774921000194/rdgdoc.xml","form_type":"4"}},{"id":3009602,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-09T23:14:46.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":44261,"source":{"system":"sec-edgar","filing":"0001437749-20-021023","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920021023/rdgdoc.xml","form_type":"4"}},{"id":3028154,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-09-17T21:18:50.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":9703,"price":10,"value":97030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":31570,"source":{"system":"sec-edgar","filing":"0001209191-20-050982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120050982/doc4.xml","form_type":"4"}},{"id":3095730,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-01T20:50:19.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted June 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":40511,"source":{"system":"sec-edgar","filing":"0001437749-20-014376","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920014376/rdgdoc.xml","form_type":"4"}},{"id":3106825,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-17T23:47:33.000Z","date":"2020-06-16","kind":"sale","acquired":false,"shares":9720,"price":9.5,"value":92340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":41273,"source":{"system":"sec-edgar","filing":"0001209191-20-037439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120037439/doc4.xml","form_type":"4"}},{"id":3113229,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-12T00:05:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":50993,"source":{"system":"sec-edgar","filing":"0001209191-20-036125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120036125/doc4.xml","form_type":"4"}},{"id":3141456,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-21T00:54:34.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted May 8, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death."}],"balance_after":36761,"source":{"system":"sec-edgar","filing":"0001437749-20-011478","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920011478/rdgdoc.xml","form_type":"4"}},{"id":3149549,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-14T20:08:58.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of May 12, 2021 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":22000,"derivative":{"exercise_price":0.43,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-20-029153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919120029153/doc4.xml","form_type":"4"}},{"id":3164252,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-05T01:32:02.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan."}],"balance_after":27961,"source":{"system":"sec-edgar","filing":"0001437749-20-009336","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920009336/rdgdoc.xml","form_type":"4"}},{"id":3164251,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-05T01:32:02.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award relates to vested restricted stock units (\"RSUs\") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan."}],"balance_after":24211,"source":{"system":"sec-edgar","filing":"0001437749-20-009336","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920009336/rdgdoc.xml","form_type":"4"}},{"id":3430441,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-08-23T10:24:48.000Z","date":"2019-07-26","kind":"exercise","acquired":false,"shares":3594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019.  The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019), which vested on July 26, 2019.  The common stock into which such vested RSUs converted on July 26, 2019 is reported on Table I of this Form 4."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3594},"source":{"system":"sec-edgar","filing":"0001437749-19-017328","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919017328/rdgdoc.xml","form_type":"4"}},{"id":3430440,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-23T10:24:48.000Z","date":"2019-07-26","kind":"exercise","acquired":true,"shares":3594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of RSUs into common stock.  On July 26, 2018, the reporting person was granted 32,353 RSUs (3,594 after the 1-for-9 reverse split effective May 7, 2019) that were previously reported on Table II of Form 4, which form was filed with the SEC on September 26, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The converted RSU corresponds to a 1:1 common stock issuance."}],"balance_after":3961,"source":{"system":"sec-edgar","filing":"0001437749-19-017328","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919017328/rdgdoc.xml","form_type":"4"}},{"id":3492558,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-13T00:42:34.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":19423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":25245,"source":{"system":"sec-edgar","filing":"0001209191-19-036574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119036574/doc4.xml","form_type":"4"}},{"id":3526573,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-15T20:48:29.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of May 14, 2020 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":7000,"derivative":{"exercise_price":4.02,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-19-030055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919119030055/doc4.xml","form_type":"4"}},{"id":3807782,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-09-27T01:17:48.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":32353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date.  Vested shares will be delivered to the Reporting Person on July 26, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date.  Vested shares will be delivered to the Reporting Person on July 26, 2019."}],"balance_after":32353,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":32353},"source":{"system":"sec-edgar","filing":"0001437749-18-017512","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918017512/rdgdoc.xml","form_type":"4"}},{"id":3810079,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-09-21T20:53:11.000Z","date":"2018-09-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in monthly installments over one year commencing one month from September 20 2018."}],"balance_after":12000,"derivative":{"exercise_price":2.56,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-051909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919118051909/doc4.xml","form_type":"4"}},{"id":3893662,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-14T23:10:00.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":5822,"source":{"system":"sec-edgar","filing":"0001209191-18-037876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118037876/doc4.xml","form_type":"4"}},{"id":4212012,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-12T19:15:15.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant.  All other terms remain the same."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in monthly installments over 36 months commencing one month from August 1, 2017."}],"balance_after":16400,"derivative":{"exercise_price":2.89,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-17-052399","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117052399/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-03"}},{"id":4224768,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Director Stock Option (right to buy)","published_at":"2017-08-25T21:47:54.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":156583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the shares subject to the option vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":156583,"derivative":{"exercise_price":0.4,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":156583},"source":{"system":"sec-edgar","filing":"0001437749-17-015346","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774917015346/rdgdoc.xml","form_type":"4"}},{"id":4244372,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-08-04T00:52:34.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in monthly installments over 36 months commencing one month from August 1, 2017."}],"balance_after":16400,"derivative":{"exercise_price":4.57,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-17-047586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919117047586/doc4.xml","form_type":"4"}},{"id":4282135,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-14T22:10:09.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":7604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":7604,"derivative":{"exercise_price":79.2,"expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":7604},"source":{"system":"sec-edgar","filing":"0001209191-17-039912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117039912/doc4.xml","form_type":"4"}},{"id":4488895,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Director Stock Option (right to buy)","published_at":"2017-01-18T23:39:37.000Z","date":"2017-01-13","kind":"grant","acquired":true,"shares":267000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":267000,"derivative":{"exercise_price":0.92,"expiration_date":"2027-01-13","underlying":"Common Stock","underlying_shares":267000},"source":{"system":"sec-edgar","filing":"0001437749-17-000794","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774917000794/rdgdoc.xml","form_type":"4"}},{"id":4552742,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-16T22:48:00.000Z","date":"2016-11-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"VCD\") of the option is November 14, 2016. The option vests (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the VCD and (ii) with respect to an additional 1/36th of the shares subject thereto on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":40.1,"expiration_date":"2026-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-16-150629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919116150629/doc4.xml","form_type":"4"}}]}